C4 Therapeutics, Inc. - CCCC
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Sep 21, 2026 | Chief Financial Officer | F | D | 2,775.0 | 3.39 | 9,407.25 | 382,323.0 | View | |
| Sep 21, 2026 | Chief Financial Officer | M | A | 6,250.0 | 0.0 | 0.0 | 385,098.0 | View | |
| Jul 13, 2026 | Chief Medical Officer | F | D | 7,397.0 | 4.06 | 30,031.82 | 372,406.0 | View | |
| Jul 13, 2026 | Chief Medical Officer | M | A | 15,325.0 | 0.0 | 0.0 | 379,803.0 | View | |
| Jul 02, 2026 | — | A | A | 3,341.0 | 4.34 | 14,499.94 | 74,853.0 | View | |
| Jul 02, 2026 | — | A | A | 2,650.0 | 4.34 | 11,501.0 | 71,950.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 26, 2026 | — | A | A | 62,000.0 | 0.0 | 0.0 | 62,000.0 | View | |
| Jun 04, 2026 | — | M | D | 1,070.0 | 0.0 | 0.0 | 0.0 | View | |
| Jun 04, 2026 | — | M | A | 1,070.0 | 2.11 | 2,257.7 | 69,300.0 | View | |
| Apr 03, 2026 | — | A | A | 4,259.0 | 2.7 | 11,499.3 | 68,230.0 | View | |
| Apr 03, 2026 | — | A | A | 5,370.0 | 2.7 | 14,499.0 | 71,512.0 | View |